Asymptomatic pulmonary hypertension in systemic lupus erythematosus

Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders

Volumn 4, Issue , 2011, Pages 77-86

  Kamel, Shereen R ^a   Omar, Gihan M ^a   Darwish, Ayman F ^a   Asklany, Hany T ^a   Ellabban, Abdou S ^a  

^a MINIA UNIVERSITY   (Egypt)

Author keywords

Echocardiography; Pulmonary hypertension; Screening; Systemic lupus erythematosus

Indexed keywords

CARDIOLIPIN ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD PRESSURE MEASUREMENT; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DOPPLER ECHOCARDIOGRAPHY; HUMAN; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; ONSET AGE; PREDICTION; PULMONARY HYPERTENSION; RISK ASSESSMENT; SCHOOL CHILD; SCREENING TEST; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTOLIC BLOOD PRESSURE; THORAX RADIOGRAPHY;

EID: 80455129394     PISSN: 11795441     EISSN: 11795441     Source Type: Journal    
DOI: 10.4137/CMAMD.S7667     Document Type: Article

References (29)

1. Pisetsky DS, Gilkeson G, St Clair W. Systemic lupus erythematosus-Diagnosis and treatment. Med Clin North Am. 1997;81:113-28.
2. Falcão CA, Lucena N, Alves IC, Pessoa AL, Godoi ET. Lupus Carditis Arq Bras Cardiol. 2000;74(1):55-71.
3. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine. 1997;76(3):192-202.
4. Ciftci E, Yalcinkaya F, Ince E, et al. Pulmonary involvement in childhood-onset systemic lupus erythematosus: a report of fve cases. Rheumatology (Oxford). 2004;43(5):587-91.
5. Simonson JS, Schiller NB, Petri M, Hellmann DB. Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol. 1989;16:918-25.
6. Swigris JJ, Fischer A, Gilles J, Meehan RT, Brown KK. Pulmonary and thrombotic manifestations of systemic lupus erythematosus. Chest. 2008; 133:271-80.
7. Yeh TT, Yang YH, Lin YT, Lu CS, Chiang BL. Cardiopulmonary involvement in pediatric systemic lupus erythematosus: a twenty year retrospective analysis. J Microbiol Immunol Infect. 2007;40:525-31.
8. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, et al. Effects of the dual endothelin antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet. 2001;358:1119-23.
9. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(1 Suppl):S14-34.
10. Selimovic N, Rundqvist B, Bergh CH, et al. Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. J Heart Lung Transplant. 2007;26:927-34.
11. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classif-cation of systemic lupus erythematosus. Arthritis Rheum.1982;25:1271-7.
12. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992;35:630-40.
13. Yock PG, Popp RL. Noninvasive evaluation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation. 1984;70:657-62.
14. Currie PJ, Seward JB, Chan KL, et al. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750-6.
15. Chen LJ, Chang HC, Lu LY, et al. Prolonged survival after single lung transplantation for pulmonary hypertension secondary to systemic lupus erythematosus. J Chin Med Assoc. 2004;67:248-51.
16. Cummings P. Primary pulmonary hypertension and SLE. N Engl J Med. 1973;288:1078-9.
17. Charoenpan P, Sukumalchantra Y, Ayuthya WIN. Pulmonary hypertension in SLE: a case report. J Med Ass Thai. 1977;60:670-5.
18. Perez HD, Kramer N. Pulmonary hypertension in systemic lupus erythema-tosus: report of four cases and review of literature. Semin Arth Rheum. 1981; 11(1):177-81.
19. Sanchez O, Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary hypertension secondary to connective tissue disease. Thorax. 1999;54:273-7.
20. Haas C. Pulmonary hypertension associated with systemic lupus erythematosus. Bull Acad Natl Med. 2004;188(6):985-7.
21. Winslow TM, Ossipov MA, Fazio GP, et al. Five-year follow-up study of the prevalence and progression of pulmonary hypertension in systemic lupus erythematosus. Am Heart J. 1995;129:510-5.
22. Prabu A, Patel K, Yee CS, et al. Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus. Rheumatology (Oxford). 2009; 48:1506-11.
23. Asherson RA, Higenbottam TW, Dinh Xuan AT, Khamashta MA, Hughes GR. Pulmonary hypertension in a lupus clinic. Experience with twenty-four patients. J Rheumatol. 1990;17(10):1292-8.
24. Foïs E, Guern VL, Dupuy A, Humbert M, Mouthon L, Guillevin L. Noninvasive assessment of systolic pulmonary artery pressure in systemic lupus erythematosus: retrospective analysis of 93 patients. Clinical and Experimental Rheumatology. 2010;28:836-41.
25. Asherson RA, Mackworth-young CG, Boey ML, et al. Pulmonary hypertension in systemic lupus erythematosus. Brit Med J. 1983;287(6398): 1024-5.
26. Naslund MJ, Pearson TA, Ritter JM. A documented episode of pulmonary vaso-constriction in systemic sclerosis. Johns Hopkins Med J. 1981;148:78-80.
27. Wilson L, Tomita T, Braniecki M. Fatal pulmonary hypertension in identical twins with systemic lupus erythematosus. Hum Pathol. 1991;22:295-7.
28. Lian F, Chen D, Wang Y, et al. Clinical features and independent predictors of pulmonary arterial hypertension in systemic lupus erythematosus. Rheumatol Int. 2011, DOI 10.1007/s00296-011-1880-4.
29. Robbins IM, Gaine SP, Schilz R, Tapson VF, Rubin LJ, Loyd JE. Epoprostenol for treatment of pulmonary hypertension in patients with systemic lupus erythematosus. Chest. 2000;117:14-8.